Y-Mabs Therapeutics Overview
Y-Mabs Therapeutics Price to Sales
Price-to-Sales ratio (P/S) for YMAB.
Get informed when a big investor buys or sells
+ FollowPrice to Sales
8.61
Price to Sales
8.61
Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.
Average Price to Sales (Comparison Companies)
Price to Sales History
Price to Sales Comparison